McKesson Corp Files 8-K for Regulation FD Disclosure
Ticker: MCK · Form: 8-K · Filed: Sep 5, 2024 · CIK: 927653
Sentiment: neutral
Topics: regulatory-filing, regulation-fd
Related Tickers: MCK
TL;DR
McKesson filed an 8-K for a Reg FD disclosure, no new material info.
AI Summary
McKesson Corporation filed an 8-K on September 5, 2024, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or new material events beyond the disclosure itself. It primarily serves as a notification to the SEC regarding compliance with fair disclosure regulations.
Why It Matters
This filing indicates McKesson Corporation is adhering to regulatory disclosure requirements, ensuring all investors receive material information simultaneously.
Risk Assessment
Risk Level: low — The filing is a routine regulatory disclosure and does not contain information that would immediately impact the company's stock price or operations.
Key Players & Entities
- MCKESSON CORP (company) — Filer
- September 5, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 6555 State Hwy 161 Irving (address) — Business Address
FAQ
What is the primary purpose of this 8-K filing by McKesson Corporation?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure, ensuring compliance with fair disclosure regulations.
On what date was this 8-K report filed?
The report was filed as of September 5, 2024.
What is McKesson Corporation's state of incorporation?
McKesson Corporation is incorporated in Delaware.
Does this filing announce any new financial results or material events?
This filing is specifically for a Regulation FD Disclosure and does not appear to announce new financial results or specific material events beyond the disclosure itself.
What is McKesson Corporation's business address?
McKesson Corporation's business address is 6555 State Hwy 161, Irving.
Filing Stats: 1,152 words · 5 min read · ~4 pages · Grade level 16.1 · Accepted 2024-09-05 11:59:53
Key Financial Figures
- $0.01 — ange on which registered Common stock, $0.01 par value MCK New York Stock Exchange
- $31.75 — Diluted Share guidance in the range of $31.75 to $32.55. McKesson also indicated it a
- $32.55 — hare guidance in the range of $31.75 to $32.55. McKesson also indicated it anticipates
- $6.70 — per Diluted Share to be in the range of $6.70 to $7.00. Non-GAAP Financial Measures
- $7.00 — ed Share to be in the range of $6.70 to $7.00. Non-GAAP Financial Measures Adjust
Filing Documents
- mck-20240905.htm (8-K) — 33KB
- mck-20240905_g1.jpg (GRAPHIC) — 11KB
- 0000927653-24-000106.txt ( ) — 241KB
- mck-20240905.xsd (EX-101.SCH) — 3KB
- mck-20240905_def.xml (EX-101.DEF) — 16KB
- mck-20240905_lab.xml (EX-101.LAB) — 30KB
- mck-20240905_pre.xml (EX-101.PRE) — 17KB
- mck-20240905_htm.xml (XML) — 5KB
01
Item 7.01 Regulation FD Disclosure. McKesson Corporation participated in the Wells Fargo 2024 Healthcare Conference on September 5, 2024, as previously noticed in the company's August 7, 2024 earnings release and on its investor relations website investor.mckesson.com. During the conference webcast, McKesson affirmed fiscal 2025 full year Adjusted Earnings per Diluted Share guidance in the range of $31.75 to $32.55. McKesson also indicated it anticipates second quarter fiscal 2025 Adjusted earnings per Diluted Share to be in the range of $6.70 to $7.00. Non-GAAP Financial Measures Adjusted Earnings per Diluted Share (Non-GAAP) : We define Adjusted Earnings per Diluted Share as GAAP earnings per diluted common share attributable to McKesson, excluding per share impacts of amortization of acquisition-related intangibles, transaction-related expenses and adjustments, LIFO inventory-related adjustments, gains from antitrust legal settlements, restructuring, impairment, and related charges, claims and litigation charges, other adjustments, as well as the related income tax effects for each of these items, as applicable, divided by diluted weighted-average shares outstanding. McKesson does not provide forward-looking guidance on a GAAP basis as the company is unable to provide a quantitative reconciliation of forward-looking Non-GAAP measures to the most directly comparable forward-looking GAAP measure, without unreasonable effort. McKesson cannot reasonably forecast LIFO inventory-related adjustments, certain litigation loss and gain contingencies, restructuring, impairment and related charges, and other adjustments, which are difficult to predict and estimate. These items are generally uncertain and depend on various factors, many of which are beyond the company's control, and as such, any associated estimate and its impact on GAAP performance could vary materially. Cautionary Statements This report contains forward-looking statements within the meaning of
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 5, 2024 McKesson Corporation By: /s/ Britt J. Vitalone Britt J. Vitalone Executive Vice President and Chief Financial Officer